Company AbbVie Inc.

ABBV

US00287Y1091

Pharmaceuticals

Market Closed - Nyse Other stock markets 21:00:03 13/02/2026 GMT			5-day change	1st Jan Change
231.50 ^USD	+1.76%		+3.61%	+1.32%

02-13	China Medical University Hospital Collaborates with Ever Supreme Bio Technology to Develop Exosome Platform	CI
02-12	AbbVie sues US health agency over Botox price controls	RE

Business description: AbbVie Inc.

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease.

Net sales are distributed geographically as follows: the United States (76.4%), Germany (2.6%), Japan (2%), Canada (1.9%), China (1.6%), France (1.4%), Spain (1%), the United Kingdom (0.9%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and other (9.7%).

Number of employees: 55,000

Sales by Activity: AbbVie Inc.

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Innovative Medicines and Therapies	45.8B	56.2B	58.05B	54.32B	56.33B

See all business segments

Geographical breakdown of sales: AbbVie Inc.

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
United States	34.88B	43.51B	45.71B	41.88B	43.03B
ALL Other Countries	3.98B	4.76B	4.84B	5.04B	5.45B
Germany	1.05B	1.22B	1.34B	1.27B	1.46B
Japan	1.2B	1.09B	956M	1.01B	1.12B
Canada	1.16B	1.4B	1.16B	1.08B	1.09B
China	471M	857M	912M	950M	917M
France	797M	936M	787M	780M	776M
Spain	453M	519M	506M	501M	528M
United Kingdom	509M	497M	462M	417M	522M
Italy	379M	506M	444M	484M	511M
Brazil	406M	368M	430M	439M	464M
Australia	527M	533M	508M	472M	463M

See all geographic segments

Executive Committee: AbbVie Inc.

Manager	Title	Age	Since
Robert Michael CEO	Chief Executive Officer	55	30/06/2024
Scott Reents DFI	Director of Finance/CFO	59	22/06/2022
Roopal Thakkar CTO	Chief Tech/Sci/R&D Officer	-	31/12/2002
Azita Saleki-Gerhardt COO	Chief Operating Officer	62	30/06/2023
Liz Shea IRC	Investor Relations Contact	-	31/12/2012

See ABBVIE INC. governance

Composition of the Board of Directors: AbbVie Inc.

Director	Title	Age	Since
Roxanne Austin BRD	Director/Board Member	65	31/12/2012
William Burnside BRD	Director/Board Member	74	31/12/2012
Edward Rapp BRD	Director/Board Member	68	31/12/2012
Robert Michael CHM	Chairman	55	30/06/2025
Rebecca Roberts BRD	Director/Board Member	73	31/12/2017
Thomas Freyman BRD	Director/Board Member	71	07/05/2020
Robert Alpern BRD	Director/Board Member	75	31/12/2012
Brett Hart BRD	Director/Board Member	56	31/12/2015
Melody Meyer BRD	Director/Board Member	68	31/12/2016
Frederick Waddell BRD	Director/Board Member	72	31/12/2012

Composition of the Board of Directors

Shareholders: AbbVie Inc.

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 10.23 %	180,779,699	10.23 %	40 316 M $
BlackRock Advisors LLC 6.38 %	112,751,940	6.38 %	25 145 M $
STATE STREET CORPORATION 4.58 %	80,940,931	4.58 %	18 051 M $
JPMorgan Investment Management, Inc. 2.974 %	52,566,779	2.974 %	11 723 M $
Geode Capital Management LLC 2.525 %	44,629,980	2.525 %	9 953 M $

Name	Equities	%	Valuation
Caixa DTVM SA 0.001073 %	303,442	0.001073 %	4 M $
XP Allocation Asset Management Ltda. 0.000003 %	986	0.000003 %	13 552 $

List of ABBVIE INC. shareholders

Holdings: AbbVie Inc.

Name	Equities	%	Valuation
XILIO THERAPEUTICS, INC. 6.44%	4,347,826	6.44%	3 M $
ABBVIE INC. 0%	5,935	0%	1 M $
CARISMA THERAPEUTICS, INC. 4.44%	1,855,871	4.44%	76 091 $

Company details: AbbVie Inc.

AbbVie, Inc.

1 North Waukegan Road

60064-6400, North Chicago

+847 932 7900

http://www.abbvie.com

Group companies: AbbVie Inc.

Name	Category and Sector
AbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan Branch Operates as a biopharmaceutical company that focused on developing advanced therapies
Allergan Pharmaceuticals Ireland ULC Allergan Pharmaceuticals Ireland ULC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products	Pharmaceuticals: Major
Allergan Pharmaceuticals Ireland ULC Allergan Pharmaceuticals Ireland ULC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products	Pharmaceuticals: Major
Aptalis Pharma Canada ULC Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products	Pharmaceuticals: Major
Aptalis Pharma Canada ULC Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products	Pharmaceuticals: Major

See all subsidiaries

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
ABBVIE INC.	+1.76%	+3.61%	+20.03%	+51.71%	409B
ELI LILLY AND COMPANY	+0.33%	-1.72%	+23.18%	+199.23%	929B
JOHNSON & JOHNSON	-0.45%	+1.44%	+55.91%	+50.24%	587B
ROCHE HOLDING AG	+0.08%	+1.01%	+20.89%	+28.94%	374B
ASTRAZENECA PLC	+1.42%	+7.19%	+26.36%	+32.36%	320B
NOVARTIS AG	+1.08%	+4.32%	+27.98%	+55.61%	311B
MERCK & CO., INC.	+1.82%	-0.43%	+46.26%	+11.65%	301B
NOVO NORDISK A/S	+1.32%	+5.11%	-45.12%	-37.51%	219B
AMGEN INC.	+1.52%	-3.94%	+26.80%	+53.17%	199B
GILEAD SCIENCES, INC.	+2.09%	+1.63%	+48.90%	+80.88%	192B
Average	+1.10%	+1.96%	+25.12%	+52.63%	384.1B
Weighted average by Cap.	+0.81%	+1.58%	+27.66%	+76.96%